Association of XRCC1 genetic polymorphism with the risk of thyroid cancer in Indonesia

Authors

  • Harry Nugroho Eko Surniyantoro Center for Technology of Radiation Safety and Metrology, National Nuclear Energy Agency
  • Nabilah Adzra Fahlevi Faculty of Science and Applied Technology, Ahmad Dahlan University
  • Esa Savitri Faculty of Science and Applied Technology, Ahmad Dahlan University
  • Tur Rahardjo Center for Technology of Radiation Safety and Metrology, National Nuclear Energy Agency
  • Rita Maliza Faculty of Science and Applied Technology, Ahmad Dahlan University
  • Ayu Rosemeilia Dewi Nuclear Medicine, Dharmais Cancer Hospital
  • Yustia Tuti Nuclear Medicine, Dharmais Cancer Hospital
  • Nastiti Rahajeng Center for Technology of Radiation Safety and Metrology, National Nuclear Energy Agency
  • Yanti Lusiyanti Center for Technology of Radiation Safety and Metrology, National Nuclear Energy Agency
  • Nur Rahmah Hidayati Center for Technology of Radiation Safety and Metrology, National Nuclear Energy Agency

DOI:

https://doi.org/10.11594/nstp.2021.1104

Keywords:

Base excision repair, PCR-RFLP, Thyroid cancer, XRCC1 exon 6 and 10

Abstract

One of the important DNA repair pathways is base excision repair (BER), which plays in the human body to maintain DNA integrity, prevent cancer and DNA damage. X-ray repair cross-complementing group 1 (XRCC1) is the most important DNA repair protein in base excision repair (BER) pathways and has been reported to have a relationship with the risk of developing various cancers. The study was purposed to assess the genetic polymorphism of XRCC1 exon 6 and 10 as a risk factor for thyroid cancer. A total of 90 participants were enrolled in this study, consisted of 30 thyroid cancer patients as a case group and 60 non-cancer patients as a control group. Examination of XRCC1 genotypes was carried out by using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method and statistical analysis using a Chi-square test. In this study, we reported the frequency of XRCC1 genetic polymorphism was not significantly different between cancer patients and control groups both in exon 6 and 10, and we predict that these polymorphisms were not a risk factor for thyroid cancer (P-value>0.05). In conclusion, both mutant variants of XRCC1 exon 6 and 10 are not risk factors for thyroid cancer.  In further studies, it is necessary to assess genetic polymorphisms in populations with controlled non-genetic factors, such as diet, lifestyle, and environmental factors.

Downloads

Download data is not yet available.

Downloads

Published

06-09-2021

How to Cite

Surniyantoro, H. N. E. ., Fahlevi, N. A. ., Savitri, E. ., Rahardjo, T. ., Maliza, R. ., Dewi, A. R. ., Tuti, Y. ., Rahajeng, N. ., Lusiyanti, Y. ., & Hidayati, N. R. . (2021). Association of XRCC1 genetic polymorphism with the risk of thyroid cancer in Indonesia. Nusantara Science and Technology Proceedings, 21-26. https://doi.org/10.11594/nstp.2021.1104

Similar Articles

1-10 of 176

You may also start an advanced similarity search for this article.